1182284-45-2

118266-15-2 Benzaldehyde,3-[2-(4,8-dihydroxy-2-propyl-1,5-dioxaspiro[2.5]oct-6-yl)-1-oxopentyl]-2,6-dihydroxy-5-(1-methoxy-2-methylpropyl)-

118243-53-1 2-methylthiocarbapenem

118276-21-4 5-Isoxazolepentanol,3-methyl-

118269-95-7 6-(2-methoxyphenyl)-4-methyl-N-(2-morpholin-4-ylethyl)pyridazin-3-amine dihydrochloride

118247-68-0 Hexanoic acid, 5-methyl-3-[[(phenylmethoxy)carbonyl]amino]-, (3S)-

118269-99-1 4,6-dimethyl-N-(2-morpholin-4-ylethyl)pyridazin-3-amine dihydrochloride

118269-73-1 N-(4-methyl-6-phenylpyridazin-3-yl)ethane-1,2-diamine dihydrochloride

118269-80-0 N-(2-morpholin-4-ylethyl)-4,6-diphenylpyridazin-3-amine dihydrochloride

118266-02-7 N1-(2,4-DIFLUORO-5-NITROPHENYL)ACETAMIDE

118275-99-3 ADENOSINE-2,3-CYCLIC MONOPHOSPHOROTHIOATE, ENDO/RP-ISOMER SODIUM SALT

118270-87-4 Oxirane, methyl-,polymer with oxirane, 2-aminomethylethyl 4-nonylphenyl ether, branched, block

118243-77-9 3-FD-Daunomycin

118267-87-1 Benzene, (4-fluoro-3-methyl-3-butenyl)-, (E)-

118277-01-3 CALCITONIN N-TERMINAL FLANKING PEPTIDE (HUMAN)

118249-65-3 Phenol,4,4'-(1-methylethylidene)bis-, sulfonated,acetates

118266-49-2 Octadecanamide, N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-

118267-45-1 TU 2D

118249-63-1 Silsesquioxanes, Ph, ethoxy-terminated, polymers with ethylene glycol, terephthalic acid and trimethylolpropane

118269-84-4 N-(2-morpholin-4-ylethyl)-4-(naphthalen-2-ylmethyl)-6-phenylpyridazin-3-amine dihydrochloride

118265-95-5 1,3,2-Diazaphospholidine, 1,2,3-triphenyl-, 2-oxide